Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AGILON HEALTH, INC.

(AGL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Agilon Health : Names Chief People Officer

10/07/2021 | 04:37pm EST


ę MT Newswires 2021
All news about AGILON HEALTH, INC.
12/07AGILON HEALTH : 7 Ways Patients Experience Care Differently Under the agilon health Model
PU
12/06AGILON HEALTH, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
12/06AGILON HEALTH : Preserving Medicare Advantage
PU
11/30AGILON HEALTH : The Many Ways agilon health is Giving Back
PU
11/11agilon health to Participate in Wolfe Research Healthcare Conference
BU
11/11What Military Medicine Taught This Primary Care Physician About Delivering Value-Based ..
PU
11/03Deutsche Bank Lowers Agilon Health's Price Target to $36 From $44, Maintains Buy Rating
MT
11/02Recent Honors Showcase agilon health Business Strength
PU
11/01SVB Leerink Adjusts agilon health's Price Target to $35 from $37, Keeps Outperform Rati..
MT
10/29November 2021 Investor Presentation
PU
More news
Analyst Recommendations on AGILON HEALTH, INC.
More recommendations
Financials (USD)
Sales 2021 1 824 M - -
Net income 2021 -395 M - -
Net cash 2021 1 060 M - -
P/E ratio 2021 -23,2x
Yield 2021 -
Capitalization 9 326 M 9 326 M -
EV / Sales 2021 4,53x
EV / Sales 2022 3,21x
Nbr of Employees 550
Free-Float 98,6%
Chart AGILON HEALTH, INC.
Duration : Period :
agilon health, inc. Technical Analysis Chart | AGL | US00857U1079 | MarketScreener
Technical analysis trends AGILON HEALTH, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 23,69 $
Average target price 37,33 $
Spread / Average Target 57,6%
EPS Revisions
Managers and Directors
Steven J. Sell President, Chief Executive Officer & Director
Timothy S. Bensley Chief Financial Officer
Ronald A. Williams Chairman
Benjamin Kornitzer Chief Medical & Quality Officer
Girish Venkatachaliah Chief Technology Officer
Sector and Competitors